Benzocaine 3.5%
Generic Name: benzocaine 3.5%
Brand Names:
Men Delay Wipe
Purpose Male genital desensitizer
Overview
Purpose Male genital desensitizer
Uses
Uses For temporary male genital desensitization, helping to slow the onset of ejaculation
Dosage
Directions Apply a small amount to head and shaft of penis before intercourse, or use as directed by a doctor. Wash product off after intercourse.
Side Effects
When using this product Avoid contact with the eyes Stop use and contact a doctor if this product , used as directed, does not provide relief. Premature ejaculation may be due to a condition requiring medical supervision. you or your partner develop a rash or irritation, such as burning or itching, discontinue use. If symptoms persist, consult a doctor.
Warnings
Warnings For external use only.
Frequently Asked Questions
What is Benzocaine 3.5% used for?▼
Uses For temporary male genital desensitization, helping to slow the onset of ejaculation
What are the side effects of Benzocaine 3.5%?▼
When using this product Avoid contact with the eyes Stop use and contact a doctor if this product , used as directed, does not provide relief. Premature ejaculation may be due to a condition requiring medical supervision. you or your partner develop a rash or irritation, such as burning or itching, discontinue use. If symptoms persist, consult a doctor.
What are the important warnings for Benzocaine 3.5%?▼
Warnings For external use only.
Related Medications
Trelagliptin Succinate
trelagliptin succinate
Dosage form: POWDER. Active ingredients: TRELAGLIPTIN SUCCINATE (15 kg/15kg). Category: BULK INGREDIENT.
Mouse Epithelium
mouse epithelium
Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS. Active ingredients: MUS MUSCULUS SKIN (.05 g/mL). Category: BLA.
Brexucabtagene Autoleucel
brexucabtagene autoleucel
11 DESCRIPTION TECARTUS (brexucabtagene autoleucel) is a CD19-directed genetically modified autologous T cell immunotherapy. To prepare TECARTUS, a patient's own T cells are harvested and genetically modified ex vivo by retroviral transduction to express a chimeric antigen receptor (CAR) comprising a murine anti-CD19 single-chain variable fragment (scFv) linked to CD28 and CD3-zeta co-stimulatory domains.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.